An Intro to Medical Device Clinical Studies

Why are clinical studies necessary?

Medical device clinical studies provide evidence for a PMA submission. Under 21 CFR 860.7, the FDA relies only on “valid scientific evidence” to determine whether there is reasonable assurance that a device is safe and effective. Valid scientific evidence can originate from a variety of sources, including well-controlled studies. Even though there are options other than clinical studies to serve as the evidence for a PMA, 21 CFR 860.7(e)(2) emphasizes the use of well-controlled studies more than any other type of evidence.


What are the stages of medical device clinical studies?

  1. Exploratory Stage – first-in-human and feasibility studies, iterative learning, & product development (this stage helps better understand how the device may perform, its intended use, and how to select an appropriate pivotal study design)
  2. Pivotal Stage – definitive study to support the safety and effectiveness evaluation of the medical device for its intended use
  3. Postmarket Stage – includes studies intended to better understand the long-term effectiveness and safety of the device, including rare adverse events


Designing a medical device clinical study:

To design a medical device clinical study, one must consider: types of device studies, bias and variance, study objectives, subject selection, stratification, site selection, and comparative study designs. Some points to keep in mind in the key areas:

  • Types of Device Studies: clinical outcome studies are typically used for therapeutic and aesthetic devices (as well as some diagnostic devices), while diagnostic clinical performance studies are typically used for diagnostic devices
    • Clinical Outcome Studies: it is preferred that these studies be double-masked, randomized, and controlled. If masking cannot occur, bias should be addressed through controls
    • Diagnostic Clinical Performance Studies: It is preferred that these studies be masked to the third party evaluator but unmasked to the investigator.
  • Bias and Variance: an objective of a clinical study is to eliminate or reduce the bias; and, variance can be reduced by either a more efficient design or by a larger sample size

See all of the FDA’s thoughts on “Design Considerations for Pivotal Clinical Investigations for Medical Devices” here: Pivotal Stakeholder Presentation. They ended this presentation by noting that device studies “allow for a broad range of designs,” and they encourage companies to meet with the FDA for a pre-sub or IDE meeting to ask questions about medical device clinical study design.


See all of our FDA-related posts here:

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:




Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now



Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
Partners located in the US (CA, FL, MA, MN, TX) and Canada.